Meet Aaron Shafer, M.D.
Aaron Shafer, M.D., FACOG, FACS
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
About Dr. Aaron Shafer
Dr. Shafer is a Professor and Quality Officer in the Department of Gynecologic Oncology and Reproductive Medicine. His clinical interests include gestational trophoblastic disease as well as minimally invasive surgery for women with gynecologic cancer with a particular focus in robotics. He also has a strong interest in post-graduate medical education and serves as Associate Director of MD Anderson’s Gynecologic Oncology Fellowship program. In addition to seeing patients at the main campus, Dr. Shafer spends two days a week operating and seeing patients at the MD Anderson location in Sugar Land.
Dr. Shafer comes to MD Anderson after practicing at Hartford Hospital in Hartford, CT, from 2009 to 2017 where he was also on faculty at the University of Connecticut School of Medicine. There, he made significant contributions to resident education as the co-director of resident research for the OB/Gyn residency, member of the resident education committee, and site director for resident robotic training.
Dr. Shafer completed his fellowship in Gynecologic Oncology at the University of North Carolina Chapel Hill and residency at Women and Infants Hospital of Rhode Island. He is a Fellow of the American Congress of Obstetrics and Gynecology as well as the American College of Surgeons and is board certified in Obstetrics and Gynecology and Gynecologic Oncology.
Present Title & Affiliation
Primary Appointment
Professor, Department of Gynecologic Oncology & Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2002 | University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, US, MD |
| 1998 | University of Pennsylvania, Philadelphia, Pennsylvania, US, Biology, BA |
Postgraduate Training
| 2006-2009 | Clinical Fellowship, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina |
| 2002-2006 | Clinical Residency, Brown University, Providence, Rhode Island |
Board Certifications
| 2011 | American Board of Obstetrics and Gynecology, Gynecologic Oncology |
| 2009 | American Board of Obstetrics and Gynecology |
Experience & Service
Academic Appointments
Fellowship Program Director, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2023
Associate Fellowship Program Director, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2019
Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023
Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, University of Connecticut School of Medicine, Farmington, CT, 2009 - 2017
Administrative Appointments/Responsibilities
Patient Safety Quality Officer, Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Other Appointments/Responsibilities
Program Directors’ Workshop Interview Subcommittee Co-Chair, Society of Gynecologic Oncology, Chicago, IL, 2022 - Present
Co-Director of GYN Q/A Committee, Hartford Hospital Department of OB/Gyn, Boston, MD, 2016 - 2017
Co-Director of resident research curriculum, University of Connecticut Integrated Residency Program, Mansfield, CT, 2012 - 2017
Fellow, American College of Surgeons, Washington, DC, 2012 - Present
Fellow, American College of Obstetricians and Gynecologists, Washington, DC, 2011 - Present
Hartford Hospital site director for resident robotic education, University of Connecticut Integrated Residency Program, Mansfield, CT, 2010 - 2017
Attending physician, Assistant Professor of Obstetrics and Gynecology, Hartford Hospital, Hartford, CT, 2009 - 2017
Full Member, Society of Gynecologic Oncologists, Chicago, IL, 2007 - Present
Institutional Committee Activities
Member, MD Anderson Faculty Senate, 2020 - 2023
Member, Division of Surgery Value Analysis Team (VAT), 2018 - 2023
Member, Perioperative Services Value Analysis Team (VAT), 2017 - 2023
Member, Surgery Working Group Committee, 2017 - 2023
Associate Member, GMEC - Graduate Medical Education Committee, 2017 - 2023
Member, Ovarian Cancer Working Group, 2017 - 2023
Member, Ovarian Cancer Moonshot Committee, 2017 - 2023
Member, Division of Surgery Cancer Network Operations, 2017 - 2023
Honors & Awards
| 2021 | Program Director of the Year, MD Anderson Clinical Education Outstanding Graduate Medical Education Program Director Award |
| 2021 | CGCAHPS Top 10% Provider, Clinician and Group Consumer Assessment of Healthcare Providers and Systems Survey |
| 2018 | CGCAHPS Top 1% Provider, Clinician and Group Consumer Assessment of Healthcare Providers and Systems Survey |
| 2018 | APGO Excellence in Teaching, APGO Medical Education Foundation |
| 2013 | Faculty Teaching Award from the second year residents in the UConn OB/Gyn residency program |
| 2007 | Berlex Foundation Faculty Development Workshop Ft. Myers, FL |
| 2007 | Golden Tarheel Teaching Award, University of North Carolina at Chapel Hill |
| 2004 | Best Resident Performance on the Council on Residency Education in Obstetrics and Gynecology (CREOG) Examination, Brown University Medical School |
| 2003 | Top Resident Teacher of the Year, Brown University Medical School |
| 2003 | Dean’s Excellence in Teaching Award, Brown University Medical School |
| 2002 | The Lubin Robin Goldsmith Award for highest scholastic performance in Obstetrics/Gynecology, University of Pittsburgh School of Medicine |
| 2001 | Elected to Alpha Omega Alpha, University of Pittsburgh School of Medicine |
| 2000 | American Society of Clinical Pathologists Award for Academic Excellence and Achievement, University of Pittsburgh School of Medicine |
| 1998 | Phi Beta Kappa National Honor Society, University of Pennsylvania |
| 1998 | Alumni Scholarship for Pennsylvania Residents, University of Pittsburgh School of Medicine |
| 1995 | Dean’s List, University of Pennsylvania |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- How, JA, Dang, M, Lee, S, Fellman, B, Westin, SN, Sood, AK, Fleming, N, Shafer, A, Yuan, Y, Liu, J, Zhao, L, Celestino, J, Hajek, RA, Morgan, M, Parra Cuentas, ER, Laberiano Fernandez, C, Arrechedera, C, Solis Soto, LM, Schmeler, KM, Nick, AM, Lu, KH, Coleman, R, Wang, L, Jazaeri, AA. Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer. Med 6(1), 2025. e-Pub 2025. PMID: 39151421.
- Diamond, V, Gerber, K, Merli, G, Mercier, R, Shafer, A, Rosenblum, N. Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center. Gynecologic Oncology Reports 56, 2024. e-Pub 2024.
- Hinchcliff, EM, Knisely, A, Adjei, N, Fellman, B, Yuan, Y, Patel, A, Xu, C, Westin, SN, Sood, AK, Soliman, PT, Shafer, A, Fleming, N, Gershenson, DM, Vikram, R, Bathala, TK, Vining, D, Ganeshan, DM, Lu, KH, Sun, CC, Meyer, LA, Jazaeri, AA. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer 130(7):1061-1071, 2024. e-Pub 2024. PMID: 38009662.
- Morris VK, Jazaeri A, Westin SN, Pettaway C, George S, Huey RW, Grinsfelder M, Shafer A, Johnson B, Vining D, Guo M, Fellman B, Frumovitz M. Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. Oncologist 28(7):618-623, 2023. e-Pub 2023. PMID: 37104874.
- Nitecki R, Hameed N, Bhosale P, Shafer A. Growing teratoma syndrome. Int J Gynecol Cancer 33(2):299-303, 2023. e-Pub 2023. PMID: 36746506.
- Stanietzky, N, Bednarski, BK, Shafer, A, Taggart, MW, Peacock, O, Vikram, R. Rectal Adenocarcinoma Presenting as a Cervical Mass. American Journal of Case Reports 24:e941884-1-e941884-6, 2023. e-Pub 2023. PMID: 38011075.
- Batman S, Messick CA, Milbourne A, Guo M, Munsell MF, Fokom-Domgue J, Salcedo M, Deshmukh A, Dahlstrom KR, Ogburn M, Price A, Fleming ND, Taylor J, Shafer A, Cobb L, Sigel K, Sturgis EM, Chiao EY, Schmeler KM. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study. Cancer Epidemiol Biomarkers Prev 31(12):2185-2191, 2022. e-Pub 2022. PMID: 36126275.
- Hinchcliff E, Gunther J, Ponnie AE, Bednarski B, Onstad M, Shafer A, Frumovitz M, Jazaeri A, Urbauer D, Bodurka DC. A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs. J Cancer Educ 37(3):615-620, 2022. e-Pub 2022. PMID: 32839894.
- Fleming ND, Westin SN, Rauh-Hain JA, Soliman PT, Fellman BM, Coleman RL, Meyer LA, Shafer A, Cobb LP, Jazaeri A, Lu KH, Sood AK. Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer. Gynecol Oncol 162(1):65-71, 2021. e-Pub 2021. PMID: 33838925.
- Fleming ND, Westin SN, Meyer LA, Shafer A, Rauh-Hain JA, Onstad M, Cobb L, Bevers M, Fellman BM, Burzawa J, Bhosale P, Zand B, Jazaeri A, Levenback C, Coleman RL, Soliman PT, Sood AK. Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. Int J Gynecol Cancer 31(1):92-97, 2021. e-Pub 2021. PMID: 33154095.
- Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: 32675511.
- Shafer A, Gehrig P. Clinical Updates in Women's Health Care Summary: Surgical Considerations: Primary and Preventive Care Review. Obstet Gynecol 133(1):233, 2019. e-Pub 2019. PMID: 30575674.
- Essel KG, Shafer A, Bruegl A, Gershenson DM, Drury LK, Ramondetta LM, Naumann RW, Brown J. Complete Resection Is Essential in the Surgical Treatment of Gestational Trophoblastic Neoplasia. Int J Gynecol Cancer 28(8):1453-1460, 2018. e-Pub 2018. PMID: 30157165.
- Hanna RK, Poniewierski MS, Laskey RA, Lopez MA, Shafer A, Van Le L, Crawford J, Dale DC, Gehrig PA, Secord AA, Havrilesky LJ, Lyman GH. Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer. Gynecol Oncol 129(1):74-80, 2013. e-Pub 2013. PMID: 23262376.
- Shafer A, Zhou C, Gehrig PA, Boggess JF, Bae-Jump VL. Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis. Int J Cancer 126(5):1144-54, 2010. e-Pub 2010. PMID: 19688827.
- Boggess JF, Gehrig PA, Cantrell L, Shafer A, Mendivil A, Rossi E, Hanna R. Perioperative outcomes of robotically assisted hysterectomy for benign cases with complex pathology. Obstet Gynecol 114(3):585-93, 2009. e-Pub 2009. PMID: 19701039.
- Batal I, Domsic RT, Shafer A, Medsger TA, Kiss LP, Randhawa P, Bastacky S. Renal biopsy findings predicting outcome in scleroderma renal crisis. Hum Pathol 40(3):332-40, 2009. e-Pub 2009. PMID: 18973923.
- Shafer A, Boggess JF. Robotic-assisted endometrial cancer staging and radical hysterectomy with the da Vinci surgical system. Gynecol Oncol 111(2 Suppl):S18-23, 2008. e-Pub 2008. PMID: 18771796.
- Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, Fowler WC. A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy. Am J Obstet Gynecol 199(4):357.e1-7, 2008. e-Pub 2008. PMID: 18928973.
- Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?. Gynecol Oncol 111(1):41-5, 2008. e-Pub 2008. PMID: 18694588.
- Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, Fowler WC. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol 199(4):360.e1-9, 2008. e-Pub 2008. PMID: 18928974.
Other Articles
- How JA, Siedel JH, Shafer A Post-operative gastroparesis following carbohydrate loading in a diabetic patient. Gynecol Oncol Rep 36:100714, 2021. PMID: 33644283.
- Jazaeri A, Coleman RL, Sood AK, Frumovitz MM, Soliman PT, Shafer A, Cutrera JJ, Klinger M, Sharafi SE, Johnson CAL, Villanueva VF, Hinchcliff EM, Dickens A, Cain KE, Anderson JE, Lu KH, Westin SN A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice. Gynecol Oncol 151(2):374-380, 2018. PMID: 30213435.
- Ledermann JA, Luvero D, Shafer A, O'Connor D, Mangili G, Friedlander M, Pfisterer J, Mirza MR, Kim JW, Alexandre J, Oza A, Brown J Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinoma. Int J Gynecol Cancer 24(9 Suppl 3):S14-9, 2014. PMID: 25341574.
- Ashton E, Szutowska M, Shafer A, Hoffman J Attempted conservative management of a placental site trophoblastic tumor: a case report. Conn Med 78(8):475-7, 2014. PMID: 25314886.
- Ricci S, Shafer A, Nerenstone S, Mandavilli S, Sorosky J A surveillance conundrum: a case of 4 distinct primary malignancies in a BRCA-1 mutation carrier. Int J Gynecol Pathol 31(2):145-8, 2012. PMID: 22317870.
- Baker AM, Haeri S, Shafer A, Moldenhauer JS Maternal gastric carcinoma metastatic to the placenta. Eur J Obstet Gynecol Reprod Biol 153(2):225-6, 2010. PMID: 20674136.
Book Chapters
- Shafer, A, Gershenson, DM, Hodgson, A, Chui, MH. Malignant ovarian germ cell tumors, 3-20, 2023.
- Cun, Han T, Shafer A. Gestational Trophoblastic Disease. In: The MD Anderson Manual of Medical Oncology. 4e. McGraw Hill, 2022.
- Shafer A, Gershenson DM, Hodgson A, and Chui MH. Malignant Ovarian Germ Cell Tumors. In: Diagnosis and Treatment of Rare Gynecologic Cancers. 1e, 2022.
- Clarke-Pearson DL, Shafer A. Perioperative Considerations for Coexisting Medical Conditions. In: Clinical Updates in Women’s Health Care, 2010.
- Shafer A, Van Le L. Endometrial Hyperplasia. In: Gynecological Cancer Management: Identification, Diagnosis and Treatment. Wiley-Blackwell, 2009.
- Shafer A, Boggess JB. “The Robotic Revolution: Coming soon to a hospital near you?”. In: Contemporary OB/Gyn Technology, 2007.
Selected Presentations & Talks
Local Presentations
- 2019. Minimally Invasive Surgical Entry Techniques: Tips & Tricks. Conference. The MD Anderson, Mayo Clinic and Memorial Sloan Kettering Conference. Houston, TX, US.
- 2019. Pelvic Anatomy and Robotic Approach to Simple Hysterectomy. Conference. The MD Anderson, Mayo Clinic and Memorial Sloan Kettering Conference. Houston, TX, US.
National Presentations
- 2021. Program Committee Member; Annual Winter Meeting. Conference. Society of Gynecologic Oncology, US.
- 2020. Scientific Program Committee; Annual Winter Meeting. Conference. Society of Gynecologic Oncology, US.
- 2019. Tumor Board Discussant; Annual Winter Meeting. Conference. Society of Gynecologic Oncology. Lake Tahoe, CA, US.
- 2019. Tumor Board Discussant; Annual Winter Meeting. Invited. SGO. Lake Tahoe, CA, US.
- 2018. Tumor Board Discussant; Annual Winter Meeting. Invited. SGO. Aspen, CO, US.
- 2016. “My Cancer has Returned. Now What?”. Invited. Foundation for Women’s Cancer Survivors Course. New Britian, CT, US.
- 2016. Combined Chemotherapy and Radiation in the Treatment of Advanced Endometrial Cancer. Conference. Poster presentation at Connecticut OB/Gyn Research Day. St. Francis Hospital. Hartford, CT, US.
- 2015. SGO Sunrise Session Faculty “GTN: Managing her headache and yours”. Invited. SGO Annual Meeting on Women’s Cancer. Chicago, US.
- 2014. “What’s in Your Genes? What You Need to Know About Breast and Ovarian Cancer.”. Invited. The bi-annual Lion of Judah Conference. New York City, NY, US.
- 2013. “Attempted Conservative Management of a Placental Site Trophoblastic Tumor.”. Invited. Oral Presentation at the NEAGO meeting, US.
- 2013. Fecal diversion after colorectal resections in ovarian cancer debulking. Conference. Poster Presentation at the ASCRS Annual Meeting. Phoenix, AZ, US.
- 2011. Utility of Frozen Section in Pre-Operative Grade 1 Endometrial Cancer. Invited. Presented at the 32nd Annual NEAGO Meeting. Stowe Mountain Lodge, Stowe, VT, US.
- 2010. DES Comes Full Circle: The first clear cell carcinoma patient undergoes definitive therapy for high grade cervical dysplasia. Invited. Presented at the 31st Annual NEAGO meeting. Boothbay Harbor, MN, US.
- 2009. Improved Survival with Consolidation Chemotherapy After Adjuvant Paclitaxel and Carboplatin in Advanced Epithelial Ovarian Cancer (EOC). Conference. Poster at the 2009 Annual Meeting of the Society of Gynecologic Oncologists. San Antonio, TX, US.
- 2008. Improved Survival with Consolidation Chemotherapy After Adjuvant Paclitaxel and Carboplatin in Advanced Epithelial Ovarian Cancer (EOC). Invited. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society. Washington, DC, US.
- 2008. Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis. Conference. Poster at the 2008 Annual Meeting of the AACR. San Diego, CA, US.
- 2008. What is the optimal minimally invasive surgical procedure for endometrial cancer in the obese and morbidly obese woman?. Invited. Oral Presentation at the 39th Annual Meeting of the Society of Gynecologic Oncologists. Tampa, FL, US.
- 2008. Surgical Cytoreduction and Dose Intensity of Adjuvant Paclitaxel and Carboplatin in Advanced Epithelial Ovarian Cancer. Conference. Poster at the 2008 Annual Meeting of the Society of Gynecologic Oncologists. Tampa, FL, US.
- 2007. Type III radical hysterectomy for obese women with cervical carcinoma: Robotic versus open. Invited. Oral Presentation at the 2007 Annual Meeting of the Society of Gynecologic Oncologists. San Diego, CA, US.
- 2007. Robotic assistance improves minimally invasive surgery for endometrial cancer. Conference. Poster at the 2007 Annual Meeting of the Society of Gynecologic Oncologists. San Diego, CA, US.
- 2005. Microvessel Density Counts and Groin Lymph Node Metastases in Vulvar Cancer. Invited. Oral Presentation at the Annual meeting of the New England Association of Gynecologic Oncology. Mt. Washington, NH, US.
- 2003. Neonatal Encephalopathy and Cerebral Palsy. Rhode Island Section ACOG Clinical Update and Risk Management Conference - This was a presentation of the findings of the ACOG Task Force on neonatal encephalopathy and cerebral palsy. Conference. Rhode Island Section ACOG Clinical Update and Risk Management Conference. Providence, RI, US.
- 2000. Clinicopathologic prognostic factors in Scleroderma Renal Crisis (SRC). Conference. Poster presentation at the Annual Meeting of the United States and Canadian Academy of Pathology. New Orleans, LA, US.
International Presentations
- 2021. Gestational Trophoblastic Disease. Invited. 2nd Annual International Web Conference on Rare Gynecologic Tumors. Moscow, RU.
- 2019. Correlation of surgeon radiology assessment with laparoscopic scoring in patients with advanced stage ovarian cancer. Invited. 2019 ASCO Annual Meeting. Chicago, US.
- 2008. Robotic Assisted Laparoscopic Cystectomy in Pregnancy: A Case Series. Invited. Oral Presentation at MIRA 2008 International Meeting, IT.
Formal Peers
- 2023. “Updates in management of GTD.”. Invited. Hartford Hospital Grand Rounds. Hartford, CT, US.
- 2022. “Updates on Malignant Ovarian Germ Cell Tumors.”. Invited. Presented at the Mexican Society of Gynecologic Oncology Annual Meeting, Playa del Carmen, MX.
- 2022. “Educational Challenges and Perspectives.”. Invited. Presented at the Felix Rutledge Society Annual Meeting, Playa del Carmen, MX.
- 2021. “Gestational trophoblastic neoplasia/choriocarcinoma.”. Invited. Presented to Oncologists in Zambia as part of the ECHO Lecture Series, ZM.
- 2019. "Innovative Treatments in Cervical Cancer". Invited. Medical Oncology and Hematology 2019: Multidisciplinary Approaches that Improve Outcomes, MD Anderson Cancer Center. Houston, TX, US.
- 2016. “Cervical Cancer Screening Update”. Invited. Backus Hospital Department of OB/GYN Grand Rounds. Norwich, CT, US.
- 2015. “Lynch Syndrome”. Invited. Backus Hospital Department of OB/GYN Grand Rounds. Norwich, CT, US.
- 2013. “Vaginal Cuff Infections and Their Management”. Invited. Grand Rounds Presentation at Reading Hospital. West Reading, PA, US.
- 2012. “Robotics and Gynecology”. Invited. OB/GYN Grand Rounds at University of Vermont. Burlington, VT, US.
- 2008. “Gynecologic Malignancy in Pregnancy”. Invited. OB/GYN Grand Rounds at UNC-Wilmington. Wilmington, NC, US.
- 2008. “Gynecologic Malignancies”. Invited. Women’s Health Issues 2008 Conference for primary care nurses. Friday Center for Continuing Education. Chapel Hill, US.
- 2007. “Incorporating Robotic Surgery in a Training Program.”. Invited. OB/GYN Grand Rounds at Hartford Hospital. Hartford, CT, US.
- 2007. “Incorporating Robotic Surgery in a Training Program”. Invited. The 1st annual International Gynecologic Oncology Robotics Society (IGORS) conference. Chapel Hill, NC, US.
- 2007. “Endometrial Hyperplasia.”. Invited. OB/GYN Grand Rounds at UNC-Wilmington. Wilmington, NC, US.
- 2007. “Endometrial Cancer and the Role of mTOR inhibitors”. Invited. OB/GYN Grand Rounds at University of North Carolina at Chapel Hill. Chapel Hill, NC, US.
- 2007. “Type III radical hysterectomy for obese women with cervical carcinoma: Robotic versus open”. Invited. OB/GYN Grand Rounds at University of North Carolina at Chapel Hill. Chapel Hill, NC, US.
- 2007. “Gestational Trophoblastic Disease”. Invited. OB/GYN Grand Rounds at UNC-Wilmington. Wilmington, NC, US.
Patient Reviews
CV information above last modified March 19, 2025